Menivim New (Israel) Performance
| MNRT Stock | ILA 197.00 0.70 0.36% |
On a scale of 0 to 100, Menivim New holds a performance score of 20. The company secures a Beta (Market Risk) of -0.21, which conveys not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Menivim New are expected to decrease at a much lower rate. During the bear market, Menivim New is likely to outperform the market. Please check Menivim New's jensen alpha, sortino ratio, maximum drawdown, as well as the relationship between the total risk alpha and treynor ratio , to make a quick decision on whether Menivim New's current price movements will revert.
Risk-Adjusted Performance
20 of 100
Weak | Strong |
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Menivim The New are ranked lower than 20 (%) of all global equities and portfolios over the last 90 days. Despite somewhat uncertain basic indicators, Menivim New sustained solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 155.8 M | |
| Total Cashflows From Investing Activities | -147.3 M | |
| Free Cash Flow | 93.9 M |
Menivim |
Menivim New Relative Risk vs. Return Landscape
If you would invest 17,070 in Menivim The New on August 25, 2024 and sell it today you would earn a total of 2,630 from holding Menivim The New or generate 15.41% return on investment over 90 days. Menivim The New is generating 0.3121% of daily returns and assumes 1.1753% volatility on return distribution over the 90 days horizon. Simply put, 10% of stocks are less volatile than Menivim, and 94% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Menivim New Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Menivim New's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Menivim The New, and traders can use it to determine the average amount a Menivim New's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.2655
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | MNRT | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 1.18 actual daily | 10 90% of assets are more volatile |
Expected Return
| 0.31 actual daily | 6 94% of assets have higher returns |
Risk-Adjusted Return
| 0.27 actual daily | 20 80% of assets perform better |
Based on monthly moving average Menivim New is performing at about 20% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Menivim New by adding it to a well-diversified portfolio.
Menivim New Fundamentals Growth
Menivim Stock prices reflect investors' perceptions of the future prospects and financial health of Menivim New, and Menivim New fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Menivim Stock performance.
| Return On Equity | 0.12 | |||
| Return On Asset | 0.0273 | |||
| Profit Margin | 1.04 % | |||
| Operating Margin | 0.69 % | |||
| Current Valuation | 2.15 B | |||
| Shares Outstanding | 689.98 M | |||
| Price To Book | 0.80 X | |||
| Price To Sales | 7.72 X | |||
| Revenue | 123.78 M | |||
| EBITDA | 173.66 M | |||
| Cash And Equivalents | 359.43 M | |||
| Cash Per Share | 0.65 X | |||
| Total Debt | 1.02 B | |||
| Debt To Equity | 0.81 % | |||
| Book Value Per Share | 2.09 X | |||
| Cash Flow From Operations | 93.91 M | |||
| Earnings Per Share | 0.25 X | |||
| Total Asset | 2.39 B | |||
About Menivim New Performance
By analyzing Menivim New's fundamental ratios, stakeholders can gain valuable insights into Menivim New's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Menivim New has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Menivim New has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Menivim - The New Reit Ltd is headquartered in Tel Aviv, Israel. MENIVIM REIT is traded on Tel Aviv Stock Exchange in Israel.Things to note about Menivim The New performance evaluation
Checking the ongoing alerts about Menivim New for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Menivim The New help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| About 57.0% of the company shares are owned by institutional investors |
- Analyzing Menivim New's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Menivim New's stock is overvalued or undervalued compared to its peers.
- Examining Menivim New's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Menivim New's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Menivim New's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Menivim New's stock. These opinions can provide insight into Menivim New's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Menivim Stock analysis
When running Menivim New's price analysis, check to measure Menivim New's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Menivim New is operating at the current time. Most of Menivim New's value examination focuses on studying past and present price action to predict the probability of Menivim New's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Menivim New's price. Additionally, you may evaluate how the addition of Menivim New to your portfolios can decrease your overall portfolio volatility.
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Stocks Directory Find actively traded stocks across global markets | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |